Healthcare Triangle is trading 15.65% higher in pre-market at $1.00, up from its September 22 close of $0.86; no verified company-specific catalyst has been identified.

  • No verified September 23, 2026 company-specific announcement was identified.
  • The latest widely surfaced company news was the September 17 Kanzun-ARCB Growth Fund partnership, which appears stale rather than a confirmed overnight catalyst.
  • Broader markets are slightly lower and do not clearly explain the move.